Showing results (81-90 of 124) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
Biomarkers of response to Akt inhibitor MK-2206 in breast cancerTakafumi Sangai, Argun Akcakanat, Huiqin Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancerAmal Melhem-Bertrandt, Mariana Chavez-Macgregor, Xiudong Lei, et al.Annals of Surgical Oncology|September 28, 2011
Triple-negative breast cancer is not a contraindication for breast conservationFarrell C Adkins, Ana Maria Gonzalez-Angulo, Xiudong Lei, et al.Breast Cancer Research and Treatment|March 23, 2010
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survivalWendy A Woodward, Pauline T Truong, Tse-Kuan Yu, et al.Molecular Cancer Therapeutics|September 30, 2010
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancerDavid Luyimbazi, Argun Akcakanat, Priscilla F McAuliffe, et al.Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancerLeonel F Hernandez-Aya, Mariana Chavez-Macgregor, Xiudong Lei, et al.Cancer|October 19, 2011
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancerStacy Moulder, Gregory Gladish, Joe Ensor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacodynamic markers of perifosine efficacyBryan T Hennessy, Yiling Lu, Enrique Poradosu, et al.Breast Cancer Research : BCR|August 17, 2017
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancerNatalia Paez Arango, Erkan Yuca, Ming Zhao, et al.Pageof 13